BIM Internal Medicine ITE
Enhanced Internal Medicine Board-Style Study
Guide
2026–2027 Edition • Original Review • Clinical Reasoning • Practice Questions
Built from the public preview of the referenced Stuvia resource and current ABIM exam information.
This is an independently written study resource. It is not the official ABIM examination, an actual exam form, or a reproduction
of paid test-bank material.
BIM Internal Medicine ITE — Original 2026–2027 Study Guide Page 1
, 1. Exam Orientation & Blueprint
The referenced Stuvia listing is a 71-page Q&A; resource uploaded February 24, 2026. Its public preview is organized around
cardiovascular medicine and includes acute coronary syndrome, ischemic stroke, hypertension, HFrEF, atrial fibrillation, aortic
stenosis, pulmonary embolism, NSTEMI and other internal-medicine scenarios. ■cite■turn0view0■
ABIM states that its Internal Medicine Certification Examination assesses knowledge, diagnostic reasoning and clinical judgment,
with most questions presented as patient-based clinical stems and single-best answers. The current ABIM blueprint is updated for
currency and assigns the largest weights to cardiovascular disease (14%), endocrinology/diabetes/metabolism (9%),
gastroenterology (9%), infectious disease (9%), pulmonary disease (9%), and rheumatology/orthopedics (9%).
■cite■turn0search0■turn0search38■
ABIM category Typical weight
Cardiovascular Disease 14%
Endocrinology, Diabetes & Metabolism 9%
Gastroenterology 9%
Infectious Disease 9%
Pulmonary Disease 9%
Rheumatology & Orthopedics 9%
Hematology 6%
Nephrology & Urology 6%
Medical Oncology 6%
Neurology 4%
Psychiatry 4%
Dermatology 3%
Obstetrics & Gynecology 3%
Geriatric Syndromes 3%
Allergy & Immunology 2%
Miscellaneous 2%
Ophthalmology 1%
Otolaryngology/Dental Medicine 1%
The blueprint is a guide to content representation, not a prediction of exact questions. ABIM also notes that multiple exam forms
differ in order and content and can include ECGs, radiographs and photomicrographs. ■cite■turn0search0■
BIM Internal Medicine ITE — Original 2026–2027 Study Guide Page 2
, 2. Cardiovascular Medicine
Acute Coronary Syndrome
• STEMI requires rapid recognition and reperfusion planning; do not delay reperfusion to wait for a confirmatory troponin when the
ECG and clinical presentation establish the diagnosis.
• NSTEMI is myocardial infarction without persistent ST elevation; risk stratification guides invasive strategy.
• Obtain and interpret an ECG rapidly in suspected ACS. The 2025 ACC/AHA guideline emphasizes rapid ECG assessment and
contemporary high-sensitivity troponin pathways. ■cite■turn1search8■turn1search9■
• Give antiplatelet/antithrombotic therapy when indicated and manage ischemia, hemodynamics and bleeding risk.
Heart Failure
Syndrome High-yield reasoning
HFrEF Use guideline-directed disease-modifying therapy; commonly includes ARNI/ACEi/ARB, evidence-based beta-blocker, MRA and
Acute decompensation Assess perfusion and congestion; IV loop diuretic is central for significant volume overload.
Cardiogenic shock Hypotension + hypoperfusion; urgent hemodynamic support and treatment of the cause.
HFpEF Treat congestion and comorbidities; SGLT2 inhibitors have an important contemporary role.
Atrial Fibrillation
Separate two questions: Is the patient unstable? and How should stroke risk be addressed? Hemodynamic instability can
require synchronized cardioversion. Stable AF with rapid ventricular response commonly begins with rate control using an
appropriate beta-blocker or nondihydropyridine calcium-channel blocker, with exceptions such as significant decompensated
HFrEF.
Valvular Disease
• Severe symptomatic aortic stenosis is a valve-intervention disease; medical therapy does not reverse the fixed obstruction.
• Mitral regurgitation: think volume overload, LV remodeling and mechanism (primary vs secondary).
• Endocarditis: persistent bacteremia, new regurgitant murmur, embolic phenomena and risk factors should prompt blood cultures
and echocardiographic evaluation.
BIM Internal Medicine ITE — Original 2026–2027 Study Guide Page 3
Enhanced Internal Medicine Board-Style Study
Guide
2026–2027 Edition • Original Review • Clinical Reasoning • Practice Questions
Built from the public preview of the referenced Stuvia resource and current ABIM exam information.
This is an independently written study resource. It is not the official ABIM examination, an actual exam form, or a reproduction
of paid test-bank material.
BIM Internal Medicine ITE — Original 2026–2027 Study Guide Page 1
, 1. Exam Orientation & Blueprint
The referenced Stuvia listing is a 71-page Q&A; resource uploaded February 24, 2026. Its public preview is organized around
cardiovascular medicine and includes acute coronary syndrome, ischemic stroke, hypertension, HFrEF, atrial fibrillation, aortic
stenosis, pulmonary embolism, NSTEMI and other internal-medicine scenarios. ■cite■turn0view0■
ABIM states that its Internal Medicine Certification Examination assesses knowledge, diagnostic reasoning and clinical judgment,
with most questions presented as patient-based clinical stems and single-best answers. The current ABIM blueprint is updated for
currency and assigns the largest weights to cardiovascular disease (14%), endocrinology/diabetes/metabolism (9%),
gastroenterology (9%), infectious disease (9%), pulmonary disease (9%), and rheumatology/orthopedics (9%).
■cite■turn0search0■turn0search38■
ABIM category Typical weight
Cardiovascular Disease 14%
Endocrinology, Diabetes & Metabolism 9%
Gastroenterology 9%
Infectious Disease 9%
Pulmonary Disease 9%
Rheumatology & Orthopedics 9%
Hematology 6%
Nephrology & Urology 6%
Medical Oncology 6%
Neurology 4%
Psychiatry 4%
Dermatology 3%
Obstetrics & Gynecology 3%
Geriatric Syndromes 3%
Allergy & Immunology 2%
Miscellaneous 2%
Ophthalmology 1%
Otolaryngology/Dental Medicine 1%
The blueprint is a guide to content representation, not a prediction of exact questions. ABIM also notes that multiple exam forms
differ in order and content and can include ECGs, radiographs and photomicrographs. ■cite■turn0search0■
BIM Internal Medicine ITE — Original 2026–2027 Study Guide Page 2
, 2. Cardiovascular Medicine
Acute Coronary Syndrome
• STEMI requires rapid recognition and reperfusion planning; do not delay reperfusion to wait for a confirmatory troponin when the
ECG and clinical presentation establish the diagnosis.
• NSTEMI is myocardial infarction without persistent ST elevation; risk stratification guides invasive strategy.
• Obtain and interpret an ECG rapidly in suspected ACS. The 2025 ACC/AHA guideline emphasizes rapid ECG assessment and
contemporary high-sensitivity troponin pathways. ■cite■turn1search8■turn1search9■
• Give antiplatelet/antithrombotic therapy when indicated and manage ischemia, hemodynamics and bleeding risk.
Heart Failure
Syndrome High-yield reasoning
HFrEF Use guideline-directed disease-modifying therapy; commonly includes ARNI/ACEi/ARB, evidence-based beta-blocker, MRA and
Acute decompensation Assess perfusion and congestion; IV loop diuretic is central for significant volume overload.
Cardiogenic shock Hypotension + hypoperfusion; urgent hemodynamic support and treatment of the cause.
HFpEF Treat congestion and comorbidities; SGLT2 inhibitors have an important contemporary role.
Atrial Fibrillation
Separate two questions: Is the patient unstable? and How should stroke risk be addressed? Hemodynamic instability can
require synchronized cardioversion. Stable AF with rapid ventricular response commonly begins with rate control using an
appropriate beta-blocker or nondihydropyridine calcium-channel blocker, with exceptions such as significant decompensated
HFrEF.
Valvular Disease
• Severe symptomatic aortic stenosis is a valve-intervention disease; medical therapy does not reverse the fixed obstruction.
• Mitral regurgitation: think volume overload, LV remodeling and mechanism (primary vs secondary).
• Endocarditis: persistent bacteremia, new regurgitant murmur, embolic phenomena and risk factors should prompt blood cultures
and echocardiographic evaluation.
BIM Internal Medicine ITE — Original 2026–2027 Study Guide Page 3
